No regulatory approvals required for cell therapy use.
Many uses besides diabetes. A platform technology.
Day surgery only to install graft under a local anaesthetic.
A very strong hint that PNV will be involved in future funding and possible acquisition.
I think we will hear more about that sooner that later.
A lot to like about that presentation.
No regulatory approvals required for cell therapy use. Many uses...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.035(2.87%) |
Mkt cap ! $818.6M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $1.635M | 1.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18287 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 42827 | 3 |
View Market Depth
| Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |